Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Cerilliant
Argus Health
Citi
Julphar
McKinsey
Harvard Business School
Accenture

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SCOPOLAMINE

« Back to Dashboard

Clinical Trials for Scopolamine

Trial ID Title Status Sponsor Phase Summary
NCT00006399 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Alzheimer's Association Phase 2 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Eisai Inc. Phase 2 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed Pfizer Phase 2 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
NCT00006399 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease Completed National Center for Research Resources (NCRR) Phase 2 The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity for learning.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Scopolamine

Condition Name

Condition Name for Scopolamine
Intervention Trials
Healthy 6
Alzheimer Disease 4
Nausea 4
Vomiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Scopolamine
Intervention Trials
Alzheimer Disease 7
Nausea 7
Vomiting 7
Postoperative Nausea and Vomiting 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Scopolamine

Trials by Country

Trials by Country for Scopolamine
Location Trials
United States 35
France 4
Israel 3
China 3
United Kingdom 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Scopolamine
Location Trials
California 5
Texas 4
Massachusetts 4
Maryland 3
Connecticut 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Scopolamine

Clinical Trial Phase

Clinical Trial Phase for Scopolamine
Clinical Trial Phase Trials
Phase 4 14
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Scopolamine
Clinical Trial Phase Trials
Completed 20
Recruiting 9
Not yet recruiting 7
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Scopolamine

Sponsor Name

Sponsor Name for Scopolamine
Sponsor Trials
University of California, Los Angeles 3
Merck Sharp & Dohme Corp. 3
Pfizer 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Scopolamine
Sponsor Trials
Other 44
Industry 19
NIH 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Accenture
Daiichi Sankyo
Julphar
Mallinckrodt
US Army
Harvard Business School
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.